SFM
APLS

Sphera Funds Management’s Apellis Pharmaceuticals APLS Stock Holding History

Sphera Funds Management’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-60,000
Closed -$3.1M – 83
2022
Q4 		$3.1M Buy
+60,000
New +$3.18M 0.67% 38

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sphera Funds Management's APLS Position: Q2 2026 in Review

Sphera Funds Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 214,914 shares — an estimated $8.65M sold.

Sphera Funds Management first reported a position in APLS in Q2 2018 and held it in 10 quarters. The position peaked at $8.65M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Sphera Funds Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Sphera Funds Management sold 214,914 Apellis Pharmaceuticals shares in Q2 2026, an estimated $8.65M.
  • Sphera Funds Management first reported a position in Apellis Pharmaceuticals in Q2 2018 and held it in 10 quarters.
  • Sphera Funds Management's Apellis Pharmaceuticals position peaked at $8.65M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.